Vascular Access Device Market by Type (Central (Peripheral, Tunneled, Non- tunneled, Implanted Ports), Peripheral (Short, Midline, Winged)), Application (Drug, Blood, Fluid, Diagnostic), End User (Hospitals, Clinics, Ambulatory) &Region - Global Forecast to 2028

Abstract
The global vascular access device market is projected to reach USD 7.9 billion by 2028 from USD 5.6 billion in 2023, at a CAGR of 7.0% during the forecast period. Growth in the vascular access device market can primarily be attributed to factors such as the growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, and growing use of vascular access device in pediatric patients. However, the high cost involved in the placement and maintenance of vascular access device is expected to limit the growth of the vascular access device market to a certain extent during the forecast period.

In 2023, the central vascular access device segment is projected to account for the largest share of the vascular access device market

By type, vascular access device market is segmented into there are peripheral access device, central vascular access device, and accessories holding a significant portion. The central vascular access device segment is is projected to account for the largest share of the global vascular access device market in 2023. Factors such as broad usage of central vascular access device in chemotherapy and in the medication of cardiovascular disorders and chronic kidney disorders.

Drug administration is projected to account for the largest share of the vascular access device market in 2023

By application, vascular access device market is segmented into drug administration, fluid and nutrition administration,blood transfusion, and diagnostic & testing. The drug administration segment is is projected to account for the largest share of the global vascular access device market in 2023.Factors such as high use of vascular access device for drug administration, specially for the treatment of infections and cancer are driving the market growth.

By end user, hospitals accounted for the largest share of the market in 2022

By end users, vascular access device market is segmented into hospitals, clinics & ambulatory centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). In 2022, hospitals accounted for the largest market share. Factors suc as majority of vascular procedures are performed in hospital settings and also emergency care in hospitals needs VADs for blood transfusion and administration of various drugs.

By region, North America is projected to account for the largest share of the vascular access device market

By region,North America accounted for the largest share of the vascular access device market in 2023. Factors such as the presence of key players, a supportive reimbursement framework, and significant government investments in cutting-edge medical devices,rising healthcare costs, government initiatives, and an increase in disposable income are contributing to the market's growth in North America.

Break of primary participants was as mentioned below:
•By Company Type – Tier 1–55%, Tier 2–25%, and Tier 3–20%
•By Designation – C-level–43%, Director-level–32%, Others–25%
•By Region – North America–38%, Europe–23%, Asia Pacific–29%, Rest of the World- 10%

Key players in the vascular access device Market
The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), Nipro Medical Corporation (Japan), Medtronic (Ireland), Amecath (Egypt),Romsons (India), PRODIMED (France),Cook Medical (US), Access Vascular, Inc. (US), Medical Components, Inc. (US), Vygon (France), 3M (US), Argon Medical Devices (US), Guangdong Baihe Medical Technology Co., Ltd. (China), pfm medical (Germany), Medi-Tech Devices Pvt Ltd (India), Medline Industries, LP (US), Kimal (UK), Deltamed (Italy), Newtech Medical Devices (India) and Shanghai Puyi Medical Instruments Co., Ltd (China).

Research Coverage:
The report analyzes the vascular access device Market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application and end user. The report also includes a product portfolio matrix of various vascular access device products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
Analysis of key drivers (growing prevalence of lifestyle diseases,increasing number of chemotherapy procedures,increasing use of vascular access device in pediatric patients), restraints (high costs involved in the placement and maintenance of vascular access device,product recalls and failures), opportunities (technological advancements and growth in the number of hospitals) and challenges (Shortage of skilled professionals and risks associated with vascular access device) influencing the growth of vascular access device market.
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the global vascular access device Market. The report analyzes this market by type, applications and end user.
•Service Enhancement/Innovation: Detailed insights on upcoming trends in the global vascular access device Market
•Market Development: Comprehensive information on the lucrative emerging markets by applications, type and end user.
•Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global vascular access device Market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, company evaluation quadrant, and capabilities of leading players in the global vascular access device Market.

Content
Table of Contents

1INTRODUCTION25
1.1STUDY OBJECTIVES25
1.2MARKET DEFINITION25
1.2.1INCLUSIONS & EXCLUSIONS26
1.2.2MARKETS COVERED26
FIGURE 1VASCULAR ACCESS DEVICES MARKET SEGMENTATION26
1.2.3REGIONAL SEGMENTATION27
1.2.4YEARS CONSIDERED27
1.3CURRENCY27
1.4STAKEHOLDERS28
1.5SUMMARY OF CHANGES28
2RESEARCH METHODOLOGY29
2.1RESEARCH DATA29
FIGURE 2RESEARCH DESIGN29
2.1.1SECONDARY DATA30
2.1.1.1Key data from secondary sources31
2.1.2PRIMARY DATA31
FIGURE 3PRIMARY SOURCES32
2.1.2.1Key data from primary sources33
2.1.2.2Key industry insights33
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS34
2.2MARKET SIZE ESTIMATION34
FIGURE 5MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS35
FIGURE 6REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY35
FIGURE 7SEGMENTAL EXTRAPOLATION: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022)36
FIGURE 8BOTTOM-UP APPROACH: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022)37
FIGURE 9CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES38
FIGURE 10CAGR PROJECTIONS38
FIGURE 11TOP-DOWN APPROACH39
2.3MARKET BREAKDOWN & DATA TRIANGULATION40
FIGURE 12DATA TRIANGULATION METHODOLOGY40
2.4STUDY ASSUMPTIONS41
2.5LIMITATIONS41
2.5.1METHODOLOGY-RELATED LIMITATIONS41
2.6RISK ASSESSMENT41
2.7VASCULAR ACCESS DEVICES MARKET: RECESSION IMPACT41
3EXECUTIVE SUMMARY43
FIGURE 13VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)43
FIGURE 14VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)44
FIGURE 15VASCULAR ACCESS DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)44
FIGURE 16GEOGRAPHICAL SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET45
4PREMIUM INSIGHTS46
4.1VASCULAR ACCESS DEVICES MARKET OVERVIEW46
FIGURE 17GROWING PREVALENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH46
4.2ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER47
FIGURE 18HOSPITALS ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 202247
4.3VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES48
FIGURE 19CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD48
4.4REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET (2021–2028)49
FIGURE 20ASIA PACIFIC MARKET TO GROW AT HIGHEST RATE DURING FORECAST PERIOD49
4.5VASCULAR ACCESS DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES49
FIGURE 21EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD49
5MARKET OVERVIEW50
5.1INTRODUCTION50
5.2MARKET DYNAMICS50
FIGURE 22VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES50
5.2.1DRIVERS51
5.2.1.1Growing prevalence of lifestyle diseases51
5.2.1.2Increasing number of chemotherapy procedures51
5.2.1.3Growing use of vascular access devices in pediatric patients52
5.2.2RESTRAINTS52
5.2.2.1High cost associated with placement and maintenance of vascular access devices52
5.2.2.2Product recalls and failures52
5.2.3OPPORTUNITIES53
5.2.3.1Technological advancements53
5.2.3.2Growth in number of hospitals54
5.2.4CHALLENGES54
5.2.4.1Shortage of skilled professionals54
5.2.4.2Risks associated with vascular access devices54
5.3INDUSTRY TRENDS55
5.3.1MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES55
5.3.2INNOVATIONS IN CATHETER MATERIALS AND COATINGS55
5.4VALUE CHAIN ANALYSIS56
FIGURE 23MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES56
5.5ECOSYSTEM MAPPING57
5.5.1ROLE IN ECOSYSTEM57
5.6PORTER’S FIVE FORCES ANALYSIS58
5.6.1THREAT OF NEW ENTRANTS58
5.6.2INTENSITY OF COMPETITIVE RIVALRY58
5.6.3BARGAINING POWER OF BUYERS58
5.6.4BARGAINING POWER OF SUPPLIERS58
5.6.5THREAT OF SUBSTITUTES58
6VASCULAR ACCESS DEVICES MARKET, BY TYPE59
6.1INTRODUCTION60
TABLE 1VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)60
6.2CENTRAL VASCULAR ACCESS DEVICES60
TABLE 2CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)61
TABLE 3CENTRAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)61
6.2.1PERIPHERALLY INSERTED CENTRAL CATHETERS62
6.2.1.1Complications associated with PICCs to limit adoption in coming years62
TABLE 4PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)62
6.2.2TUNNELED CATHETERS63
6.2.2.1Advantages of tunneled catheters such as lower risk of infection and lower chances of accidental removal to boost demand63
TABLE 5TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)63
6.2.3NON-TUNNELED CATHETERS64
6.2.3.1High risk of infection to limit market growth64
TABLE 6NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)64
6.2.4IMPLANTED PORTS65
6.2.4.1Lowest risk of infection associated with implanted ports to support growth65
TABLE 7IMPLANTED PORTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)65
6.3PERIPHERAL VASCULAR ACCESS DEVICES66
TABLE 8PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)66
TABLE 9PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)67
6.3.1PERIPHERAL SHORT DEVICES67
6.3.1.1Ability of peripheral short devices to only administer select types of medication to hamper growth67
TABLE 10PERIPHERAL SHORT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)68
6.3.2PERIPHERAL MIDLINE DEVICES68
6.3.2.1Need for trained nurses for procedures to restrict growth68
TABLE 11PERIPHERAL MIDLINE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)69
6.3.3BUTTERFLY/WINGED STEEL NEEDLES69
6.3.3.1Wide usage of winged steel needles in blood sampling and diagnosis to propel growth69
TABLE 12BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)70
6.4ACCESSORIES70
6.4.1RECURRENT NEED FOR ACCESSORIES TO BOOST MARKET70
TABLE 13VASCULAR ACCESS DEVICE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)71
7VASCULAR ACCESS DEVICES MARKET, BY APPLICATION72
7.1INTRODUCTION73
TABLE 14VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)73
7.2DRUG ADMINISTRATION73
7.2.1HIGH USAGE OF VASCULAR ACCESS DEVICES FOR DRUG ADMINISTRATION TO BOOST SEGMENTAL GROWTH73
TABLE 15VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)74
7.3FLUID & NUTRITION ADMINISTRATION74
7.3.1GROWING USE OF PERIPHERAL VASCULAR ACCESS DEVICES FOR SHORT-TERM NUTRITIONAL THERAPY TO SUPPORT MARKET74
TABLE 16VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)75
7.4BLOOD TRANSFUSION75
7.4.1FREQUENT NEED FOR BLOOD TRANSFUSION IN TREATMENT OF VARIOUS CONDITIONS TO BOOST GROWTH75
TABLE 17VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)76
7.5DIAGNOSTICS & TESTING76
7.5.1GROWING POPULARITY OF PERIPHERAL LINES FOR DIAGNOSTIC & TESTING APPLICATIONS TO DRIVE MARKET GROWTH76
TABLE 18VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)77
8VASCULAR ACCESS DEVICES MARKET, BY END USER78
8.1INTRODUCTION79
TABLE 19VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)79
8.2HOSPITALS79
8.2.1HIGH DEMAND FOR VASCULAR ACCESS DEVICES IN HOSPITAL SETTINGS TO BOOST MARKET79
TABLE 20VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)80
8.3CLINICS & AMBULATORY CARE CENTERS80
8.3.1GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH80
TABLE 21VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)81
8.4OTHER END USERS81
TABLE 22VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)82
9VASCULAR ACCESS DEVICES MARKET, BY REGION83
9.1INTRODUCTION84
TABLE 23VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)84
9.2NORTH AMERICA84
9.2.1NORTH AMERICA: RECESSION IMPACT84
FIGURE 24NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT85
TABLE 24NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)86
TABLE 25NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)86
TABLE 26NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)86
TABLE 27NORTH AMERICA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)87
TABLE 28NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)87
TABLE 29NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)87
9.2.2US88
9.2.2.1High prevalence of chronic diseases to drive market growth88
TABLE 30INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED88
TABLE 31US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)89
TABLE 32US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)89
TABLE 33US: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)89
TABLE 34US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)90
TABLE 35US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)90
9.2.3CANADA90
9.2.3.1Increasing number of minimally invasive procedures to support market growth90
TABLE 36CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)91
TABLE 37CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)91
TABLE 38CANADA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)92
TABLE 39CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)92
TABLE 40CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)92
9.3EUROPE93
9.3.1EUROPE: RECESSION IMPACT93
TABLE 41EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)93
TABLE 42EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)94
TABLE 43EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)94
TABLE 44EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)94
TABLE 45EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)95
TABLE 46EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)95
9.3.2GERMANY95
9.3.2.1Growing geriatric and obese populations to contribute to market growth95
TABLE 47GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)96
TABLE 48GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)96
TABLE 49GERMANY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)97
TABLE 50GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)97
TABLE 51GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)97
9.3.3UK98
9.3.3.1Increasing incidence of coronary heart disease to support market growth98
TABLE 52UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)98
TABLE 53UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)99
TABLE 54UK: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)99
TABLE 55UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)99
TABLE 56UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)100
9.3.4FRANCE100
9.3.4.1Strong government support and favorable strategies & initiatives to drive market growth100
TABLE 57FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)100
TABLE 58FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)101
TABLE 59FRANCE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)101
TABLE 60FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)102
TABLE 61FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)102
9.3.5ITALY102
9.3.5.1Strong healthcare policies by government to propel growth102
TABLE 62ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)103
TABLE 63ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)103
TABLE 64ITALY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)104
TABLE 65ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)104
TABLE 66ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)104
9.3.6SPAIN105
9.3.6.1Growing geriatric population to increase demand for vascular access devices105
TABLE 67SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)105
TABLE 68SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)105
TABLE 69SPAIN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)106
TABLE 70SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)106
TABLE 71SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)106
9.3.7REST OF EUROPE107
TABLE 72REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)107
TABLE 73REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)108
TABLE 74REST OF EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)108
TABLE 75REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)109
TABLE 76REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)109
9.4ASIA PACIFIC109
9.4.1ASIA PACIFIC: RECESSION IMPACT110
FIGURE 25ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT111
TABLE 77ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 78ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)112
TABLE 79ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)112
TABLE 80ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)113
TABLE 81ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)113
TABLE 82ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)113
9.4.2JAPAN114
9.4.2.1Large geriatric population to support market growth114
TABLE 83JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)114
TABLE 84JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)115
TABLE 85JAPAN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)115
TABLE 86JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)116
TABLE 87JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)116
9.4.3CHINA116
9.4.3.1Growing target patient population to drive market growth116
TABLE 88CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)117
TABLE 89CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)117
TABLE 90CHINA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)118
TABLE 91CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)118
TABLE 92CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)118
9.4.4INDIA119
9.4.4.1Increasing prevalence of diabetes to drive adoption of vascular access devices119
TABLE 93INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)119
TABLE 94INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)120
TABLE 95INDIA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)120
TABLE 96INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)121
TABLE 97INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)121
9.4.5REST OF ASIA PACIFIC121
TABLE 98REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)122
TABLE 99REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)122
TABLE 100REST OF ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)123
TABLE 101REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)123
TABLE 102REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)123
9.5REST OF THE WORLD124
9.5.1REST OF THE WORLD: RECESSION IMPACT124
TABLE 103REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)124
TABLE 104REST OF THE WORLD: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 105REST OF THE WORLD: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 106REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)126
TABLE 107REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)126
10COMPETITIVE LANDSCAPE127
10.1OVERVIEW127
10.2STRATEGIES ADOPTED BY KEY PLAYERS127
TABLE 108OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS127
10.3REVENUE SHARE ANALYSIS130
FIGURE 26REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2020–2022)130
10.4MARKET SHARE ANALYSIS130
FIGURE 27MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2022)131
10.5MARKET RANKING ANALYSIS131
FIGURE 28VASCULAR ACCESS DEVICES MARKET: KEY PLAYER RANKING, 2022132
10.6COMPANY EVALUATION MATRIX133
10.6.1STARS133
10.6.2EMERGING LEADERS133
10.6.3PERVASIVE PLAYERS133
10.6.4PARTICIPANTS133
FIGURE 29VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)134
10.7COMPANY EVALUATION MATRIX FOR SMES/START-UPS135
10.7.1PROGRESSIVE COMPANIES135
10.7.2DYNAMIC COMPANIES135
10.7.3STARTING BLOCKS135
10.7.4RESPONSIVE COMPANIES135
FIGURE 30VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022)136
10.8COMPANY FOOTPRINT ANALYSIS137
TABLE 109COMPANY FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)137
10.8.1COMPANY FOOTPRINT, BY TYPE138
TABLE 110TYPE FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)138
10.8.2COMPANY FOOTPRINT, BY REGION139
TABLE 111REGIONAL FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022)139
10.9COMPETITIVE SCENARIO140
10.9.1PRODUCT LAUNCHES140
TABLE 112PRODUCT LAUNCHES, JANUARY 2019–JULY 2023140
10.9.2DEALS141
TABLE 113DEALS, JANUARY 2019–JULY 2023141
10.9.3OTHER DEVELOPMENTS142
TABLE 114OTHER DEVELOPMENTS, JANUARY 2019–JULY 2023142
11COMPANY PROFILES143
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
11.1KEY PLAYERS143
11.1.1BECTON, DICKINSON AND COMPANY143
TABLE 115BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW143
FIGURE 31BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)144
11.1.2TELEFLEX INCORPORATED148
TABLE 116TELEFLEX INCORPORATED: BUSINESS OVERVIEW148
FIGURE 32TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)149
11.1.3ICU MEDICAL, INC.152
TABLE 117ICU MEDICAL, INC.: BUSINESS OVERVIEW152
FIGURE 33ICU MEDICAL, INC.: COMPANY SNAPSHOT (2022)153
11.1.4B. BRAUN SE156
TABLE 118B. BRAUN SE: BUSINESS OVERVIEW156
FIGURE 34B. BRAUN SE: COMPANY SNAPSHOT (2022)157
11.1.5ANGIODYNAMICS, INC.160
TABLE 119ANGIODYNAMICS, INC.: BUSINESS OVERVIEW160
FIGURE 35ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022)161
11.1.6TERUMO CORPORATION163
TABLE 120TERUMO CORPORATION: BUSINESS OVERVIEW163
FIGURE 36TERUMO CORPORATION: COMPANY SNAPSHOT (2023)164
11.1.7NIPRO MEDICAL CORPORATION165
TABLE 121NIPRO MEDICAL CORPORATION: BUSINESS OVERVIEW165
FIGURE 37NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022)165
11.1.8MEDTRONIC167
TABLE 122MEDTRONIC: BUSINESS OVERVIEW167
FIGURE 38MEDTRONIC: COMPANY SNAPSHOT (2022)168
11.1.9AMECATH170
TABLE 123AMECATH: BUSINESS OVERVIEW170
11.1.10ROMSONS172
TABLE 124ROMSONS: BUSINESS OVERVIEW172
11.1.11PRODIMED173
TABLE 125PRODIMED: BUSINESS OVERVIEW173
11.1.12COOK MEDICAL174
TABLE 126COOK MEDICAL: BUSINESS OVERVIEW174
11.1.13ACCESS VASCULAR, INC.175
TABLE 127ACCESS VASCULAR, INC.: BUSINESS OVERVIEW175
11.1.14MEDICAL COMPONENTS, INC.176
TABLE 128MEDICAL COMPONENTS, INC.: BUSINESS OVERVIEW176
11.1.15VYGON178
TABLE 129VYGON: BUSINESS OVERVIEW178
11.2OTHER COMPANIES180
11.2.13M180
11.2.2ARGON MEDICAL DEVICES181
11.2.3GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.181
11.2.4PFM MEDICAL182
11.2.5MEDI-TECH DEVICES PVT. LTD.183
11.2.6MEDLINE INDUSTRIES, LP183
11.2.7KIMAL184
11.2.8DELTA MED184
11.2.9NEWTECH MEDICAL DEVICES185
11.2.10SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.185
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
12APPENDIX186
12.1DISCUSSION GUIDE186
12.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL190
12.3CUSTOMIZATION OPTIONS192
12.4RELATED REPORTS192
12.5AUTHOR DETAILS193